# Jubilant DraxImage Radiopharmacies Inc. dba Jubilant Radiopharma – FDA Inspection, Mar 13, 2024

Source: https://www.keypedia.com/records/fda_inspections/jubilant-draximage-radiopharmacies-inc-dba-jubilant-radiopharma/65321b70-8402-4fd8-903b-351042cbe90f
Source feed: FDA_Inspections

> FDA inspection 1232771 of Jubilant DraxImage Radiopharmacies Inc. dba Jubilant Radiopharma, March 13, 2024. Classification: Voluntary Action Indicated (VAI). 12 citations.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1232771
- Company Name: Jubilant DraxImage Radiopharmacies Inc. dba Jubilant Radiopharma
- Inspection Date: 2024-03-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 12
- Enforcement Type: STATE_REFERRAL_LETTER

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jared-p-stevens/11cd48ff-e61f-4448-98be-efe2f8377fc1)
- [FDA Associated Person](https://www.keypedia.com/people/jessica-p-mcalister/d892c069-d283-4bb0-9cbb-78e463bfc1ea)

Company: https://www.keypedia.com/companies/jubilant-draximage-radiopharmacies-inc-dba-jubilant-radiopharma/143d8ee9-878e-4e0a-9508-c1fb809dabb1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
